If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharmaceuticals Regulatory News (CEL)

  • This share is currently suspended. It was suspended at a price of 13.40
  • There is currently no data for CEL

Celadon Pharmaceuticals

5 Aug 2025 18:00

RNS Number : 0951U
FTSE Russell
05 August 2025
 

 

 

Celadon Pharmaceuticals (UK): Constituent DeletionChanges in FTSE UK Index Series

05 August 2025

Following the continued suspension and expected cancellation of trading on AIM for Celadon Pharmaceuticals (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

08 August 2025

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

Alternatively, please visit our website at lseg.com/ftse-russell

Terms of Use | Copyright © 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSEELFBEVLBBBV
Date   Source Headline
5th Jul 20073:18 pmRNSHolding(s) in Company
20th Jun 20077:00 amRNSFinal Results
16th May 20077:01 amRNSNotice of Results
15th May 20077:01 amRNSRe Appointments
19th Apr 20079:26 amRNSHolding(s) in Company
28th Mar 20077:01 amRNSTrading Update
20th Mar 200712:28 pmRNSHolding(s) in Company
16th Mar 20079:22 amRNSHolding(s) in Company
9th Mar 20078:00 amRNSHolding(s) in Company
6th Mar 200712:10 pmRNSHolding(s) in Company
5th Feb 20073:36 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSTotal Voting Rights
24th Jan 20077:01 amRNSTreasury Stock
15th Dec 20067:58 amRNSTotal Voting Rights
11th Dec 20065:41 pmRNSHolding(s) in Company
17th Nov 20067:00 amRNSDirector/PDMR Shareholding
8th Nov 20067:00 amRNSInterim Results
2nd Nov 20065:08 pmRNSHolding(s) in Company
25th Oct 20064:08 pmRNSNotice of Results
28th Sep 20067:00 amRNSPreClose Trading Update
19th Sep 20067:00 amRNSInVitro Technologies Inc
11th Sep 20064:34 pmRNSHolding(s) in Company
30th Aug 20064:38 pmRNSHolding(s) in Company
1st Aug 20065:09 pmRNSHolding(s) in Company
31st Jul 20064:47 pmRNSShare Options
26th Jul 20065:25 pmRNSResult of AGM
26th Jul 20067:01 amRNSAGM Statement
7th Jul 20064:55 pmRNSAnnual Information Update
7th Jul 20064:53 pmRNSAnnual Report and Accounts
16th Jun 20063:37 pmRNSDoc re: Acquisition
14th Jun 20067:01 amRNSAcquisition
14th Jun 20067:01 amRNSFinal Results
6th Jun 20063:13 pmRNSNotice of Results
28th Mar 20067:00 amRNSTrading Statement
10th Mar 200611:19 amRNSTreasury Stock
7th Mar 20063:58 pmRNSHolding(s) in Company
7th Mar 20063:56 pmRNSHolding(s) in Company
3rd Feb 20067:00 amRNSNew Contracts
1st Feb 200612:27 pmRNSHolding(s) in Company
30th Jan 20064:23 pmRNSHolding(s) in Company
14th Nov 20057:01 amRNSChange of Adviser
9th Nov 200510:53 amRNSHolding(s) in Company
8th Nov 20057:01 amRNSInterim Results
5th Oct 20057:00 amRNSNotice of Results
29th Sep 20057:00 amRNSTrading Statement
22nd Sep 20056:17 pmRNSTreasury Stock
22nd Sep 20057:03 amRNSRe Agreement
21st Sep 20057:00 amRNSDirector/PDMR Shareholding
30th Aug 200511:43 amRNSShare Consolidation
24th Aug 20054:22 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.